Fagan Associates’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-4,505
Closed -$260K 121
2019
Q2
$260K Buy
+4,505
New +$264K 0.11% 104
2018
Q3
Sell
-4,015
Closed -$234K 119
2018
Q2
$234K Buy
+4,015
New +$218K 0.11% 107
2016
Q3
Sell
-13,500
Closed -$751K 98
2016
Q2
$751K Sell
13,500
-19,896
-60% -$958K 0.48% 55
2016
Q1
$1.52M Buy
33,396
+2,043
+7% +$78.1K 1.01% 34
2015
Q4
$1.17M Buy
31,353
+7,021
+29% +$248K 0.78% 43
2015
Q3
$795K Buy
24,332
+10,597
+77% +$337K 0.58% 48
2015
Q2
$404K Buy
+13,735
New +$429K 0.27% 75

Other funds holding CONE

Fagan Associates's CONE Position: Q3 2019 in Review

Fagan Associates sold out of CyrusOne Inc Common Stock (CONE) in Q3 2019, closing a stake of 4,505 shares — an estimated $260K sold.

Fagan Associates first reported a position in CONE in Q2 2015 and held it in 7 quarters. The position peaked at $1.52M in Q1 2016. 395 funds tracked by Wall St. Rank hold CONE as of Q3 2019.

  • Fagan Associates reported no remaining CyrusOne Inc Common Stock position as of Q3 2019 after selling out during the quarter.
  • Fagan Associates sold 4,505 CyrusOne Inc Common Stock shares in Q3 2019, an estimated $260K.
  • Fagan Associates first reported a position in CyrusOne Inc Common Stock in Q2 2015 and held it in 7 quarters.
  • Fagan Associates's CyrusOne Inc Common Stock position peaked at $1.52M in Q1 2016.
  • 395 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q3 2019.

Based on Fagan Associates's 13F filing for Q3 2019, filed 13 Nov 2019.